Exercise of Share Options and Total Voting Rights | 21-Nov-2024 | 13:32 | RNS |
Exercise of Share Options and Total Voting Rights | 20-Nov-2024 | 08:47 | RNS |
Exercise of Share Options and Total Voting Rights | 28-Oct-2024 | 13:37 | RNS |
Final Results | 21-Oct-2024 | 07:00 | RNS |
Notice of Preliminary Results | 01-Oct-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 20-Sep-2024 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 19-Sep-2024 | 13:13 | RNS |
FDA 510(k) submission for Tristel OPH | 12-Sep-2024 | 07:00 | RNS |
Confirmation of CEO Transition, Directorate Change | 02-Sep-2024 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 06-Aug-2024 | 15:32 | RNS |
Trading Update | 22-Jul-2024 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 04-Jul-2024 | 15:43 | RNS |
Director/PDMR Shareholding | 11-Jun-2024 | 17:48 | RNS |
Holding(s) in Company | 11-Jun-2024 | 15:50 | RNS |
Appointment of CEO | 10-Jun-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 440.00p |
Change Today | 2.50p |
% Change | 0.57 % |
52 Week High | 500.00 |
52 Week Low | 350.00 |
Volume | 18,491 |
Shares Issued | 47.69m |
Market Cap | £209.82m |
RiskGrade | 180 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 28-Nov-24 | 21-Mar-24 |
Paid | 20-Dec-24 | 12-Apr-24 |
Amount | 8.28p | 5.24p |
Time | Volume / Share Price |
16:14 | 3,725 @ 440.50p |
15:51 | 902 @ 440.00p |
15:22 | 110 @ 448.00p |
15:20 | 2,400 @ 439.36p |
14:59 | 3,100 @ 448.99p |
Finance Director | Elizabeth Dixon |
CEO | Matthew (Matt) Giovanni Sassone |
You are here: research